chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site induration, Injection site pruritus, Nausea, Palpitations, Paraesthesia
Clinical narrative: watery stool; injection site was super itchy; watery stool; injection site redness; nausea; tired; two hard knots at the injection site; 45 Mins after the shot she got tingling all over the body; tight chest; heart racing; tingling tongue and throat; swelling tongue and throat; difficulty swallowing; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (45 Mins after the shot she got tingling all over the body), CHEST DISCOMFORT (tight chest), PALPITATIONS (heart racing), PARAESTHESIA ORAL (tingling tongue and throat) and SWOLLEN TONGUE (swelling tongue and throat) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Latex allergy and Sulfonamide allergy. Concomitant products included ETHAMBUTOL DIHYDROCHLORIDE (ATB) for Bronchitis.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced PARAESTHESIA (45 Mins after the shot she got tingling all over the body), CHEST DISCOMFORT (tight chest), PALPITATIONS (heart racing), PARAESTHESIA ORAL (tingling tongue and throat), SWOLLEN TONGUE (swelling tongue and throat), DYSPHAGIA (difficulty swallowing), INJECTION SITE INDURATION (two hard knots at the injection site) and FATIGUE (tired). On 11-Feb-2021, the patient experienced the first episode of DIARRHOEA (watery stool), INJECTION SITE ERYTHEMA (injection site redness) and NAUSEA (nausea). On 12-Feb-2021, the patient experienced the second episode of DIARRHOEA (watery stool) and INJECTION SITE PRURITUS (injection site was super itchy). At the time of the report, PARAESTHESIA (45 Mins after the shot she got tingling all over the body), CHEST DISCOMFORT (tight chest), PALPITATIONS (heart racing), PARAESTHESIA ORAL (tingling tongue and throat), SWOLLEN TONGUE (swelling tongue and throat), DYSPHAGIA (difficulty swallowing), the last episode of DIARRHOEA (watery stool), INJECTION SITE PRURITUS (injection site was super itchy), INJECTION SITE INDURATION (two hard knots at the injection site), INJECTION SITE ERYTHEMA (injection site redness), FATIGUE (tired) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications were not reported.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia oral, Swollen tongue
Clinical narrative: watery stool; injection site was super itchy; watery stool; injection site redness; nausea; tired; two hard knots at the injection site; 45 Mins after the shot she got tingling all over the body; tight chest; heart racing; tingling tongue and throat; swelling tongue and throat; difficulty swallowing; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (45 Mins after the shot she got tingling all over the body), CHEST DISCOMFORT (tight chest), PALPITATIONS (heart racing), PARAESTHESIA ORAL (tingling tongue and throat) and SWOLLEN TONGUE (swelling tongue and throat) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Latex allergy and Sulfonamide allergy. Concomitant products included ETHAMBUTOL DIHYDROCHLORIDE (ATB) for Bronchitis.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced PARAESTHESIA (45 Mins after the shot she got tingling all over the body), CHEST DISCOMFORT (tight chest), PALPITATIONS (heart racing), PARAESTHESIA ORAL (tingling tongue and throat), SWOLLEN TONGUE (swelling tongue and throat), DYSPHAGIA (difficulty swallowing), INJECTION SITE INDURATION (two hard knots at the injection site) and FATIGUE (tired). On 11-Feb-2021, the patient experienced the first episode of DIARRHOEA (watery stool), INJECTION SITE ERYTHEMA (injection site redness) and NAUSEA (nausea). On 12-Feb-2021, the patient experienced the second episode of DIARRHOEA (watery stool) and INJECTION SITE PRURITUS (injection site was super itchy). At the time of the report, PARAESTHESIA (45 Mins after the shot she got tingling all over the body), CHEST DISCOMFORT (tight chest), PALPITATIONS (heart racing), PARAESTHESIA ORAL (tingling tongue and throat), SWOLLEN TONGUE (swelling tongue and throat), DYSPHAGIA (difficulty swallowing), the last episode of DIARRHOEA (watery stool), INJECTION SITE PRURITUS (injection site was super itchy), INJECTION SITE INDURATION (two hard knots at the injection site), INJECTION SITE ERYTHEMA (injection site redness), FATIGUE (tired) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications were not reported.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Soreness of arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness of arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced PAIN IN EXTREMITY (Soreness of arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Soreness of arm) outcome was unknown. Not Provided          No relevant concomitant medications were reported. Other treatment medications include Warm Compress.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Bedridden, Chills, Fatigue, Nausea, Pain
Clinical narrative: He was down and out bedridden for 3 days; aches; fever; chills; nausea; tiredness; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 02-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of BEDRIDDEN (He was down and out bedridden for 3 days), PAIN (aches), PYREXIA (fever), CHILLS (chills) and NAUSEA (nausea) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ATORVASTATIN CALCIUM (ASTATIN [ATORVASTATIN CALCIUM]) for an unknown indication.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced BEDRIDDEN (He was down and out bedridden for 3 days), PAIN (aches), PYREXIA (fever), CHILLS (chills), NAUSEA (nausea) and FATIGUE (tiredness). On 27-Feb-2021, BEDRIDDEN (He was down and out bedridden for 3 days) had resolved. At the time of the report, PAIN (aches), PYREXIA (fever), CHILLS (chills), NAUSEA (nausea) and FATIGUE (tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication were reported.   Reporter did not allow further contact
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: He was down and out bedridden for 3 days; aches; fever; chills; nausea; tiredness; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 02-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of BEDRIDDEN (He was down and out bedridden for 3 days), PAIN (aches), PYREXIA (fever), CHILLS (chills) and NAUSEA (nausea) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ATORVASTATIN CALCIUM (ASTATIN [ATORVASTATIN CALCIUM]) for an unknown indication.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced BEDRIDDEN (He was down and out bedridden for 3 days), PAIN (aches), PYREXIA (fever), CHILLS (chills), NAUSEA (nausea) and FATIGUE (tiredness). On 27-Feb-2021, BEDRIDDEN (He was down and out bedridden for 3 days) had resolved. At the time of the report, PAIN (aches), PYREXIA (fever), CHILLS (chills), NAUSEA (nausea) and FATIGUE (tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication were reported.   Reporter did not allow further contact
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Gait disturbance, Gait inability, Pain, Pain in extremity
Clinical narrative: couldnt walk; hobbling; muscle pain on his calf; Hurting; This spontaneous case was reported by a consumer and describes the occurrence of GAIT INABILITY (couldnt walk), GAIT DISTURBANCE (hobbling), PAIN IN EXTREMITY (muscle pain on his calf) and PAIN (Hurting) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced GAIT INABILITY (couldnt walk), GAIT DISTURBANCE (hobbling), PAIN IN EXTREMITY (muscle pain on his calf) and PAIN (Hurting). At the time of the report, GAIT INABILITY (couldnt walk), GAIT DISTURBANCE (hobbling), PAIN IN EXTREMITY (muscle pain on his calf) and PAIN (Hurting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-098830 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-098830:Reporter's case
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling cold, Headache, Pyrexia
Clinical narrative: 102.5 degrees F; freezing; 105 degree F fever; headache; chills; little bit tired; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (freezing), FATIGUE (little bit tired), PYREXIA (105 degree F fever), HEADACHE (headache) and CHILLS (chills) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Denied) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 31-Jan-2021, the patient experienced FATIGUE (little bit tired). On 28-Feb-2021, the patient experienced FEELING COLD (freezing), PYREXIA (105 degree F fever), HEADACHE (headache) and CHILLS (chills). On 01-Mar-2021, the patient experienced PYREXIA (102.5 degrees F). On 01-Feb-2021, FATIGUE (little bit tired) had resolved. On 02-Mar-2021, FEELING COLD (freezing), PYREXIA (105 degree F fever), CHILLS (chills) and PYREXIA (102.5 degrees F) had resolved. At the time of the report, HEADACHE (headache) outcome was unknown.            No concomitant medication were reported No treatment medication were reported. The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in the event is not applicable
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia
Clinical narrative: Low grade fever; Tiredness (more tired than usual and general fatigued); This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of PYREXIA (Low grade fever) and FATIGUE (Tiredness (more tired than usual and general fatigued)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Low grade fever) and FATIGUE (Tiredness (more tired than usual and general fatigued)). At the time of the report, PYREXIA (Low grade fever) and FATIGUE (Tiredness (more tired than usual and general fatigued)) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported. Treatment medication was not reported.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Event outcome updated
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness
Clinical narrative: loss of life from her both arm.; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (loss of life from her both arm.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced MUSCULAR WEAKNESS (loss of life from her both arm.). On 27-Jan-2021, MUSCULAR WEAKNESS (loss of life from her both arm.) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medication was not reported. Treatment medication was not reported.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Hypoaesthesia, Somnolence
Clinical narrative: Numbness on Face, Jaw and Lower Lips; Dizziness; Felt sleepy; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness on Face, Jaw and Lower Lips), DIZZINESS (Dizziness), SOMNOLENCE (Felt sleepy) and HEADACHE (Headache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to vaccine (Allergy to flu vaccine) and Egg allergy.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced HYPOAESTHESIA (Numbness on Face, Jaw and Lower Lips), DIZZINESS (Dizziness), SOMNOLENCE (Felt sleepy) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 01-Mar-2021, DIZZINESS (Dizziness), SOMNOLENCE (Felt sleepy) and HEADACHE (Headache) had resolved. At the time of the report, HYPOAESTHESIA (Numbness on Face, Jaw and Lower Lips) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal discomfort
Clinical narrative: Throat pulses for two weeks; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL DISCOMFORT (Throat pulses for two weeks) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL DISCOMFORT (Throat pulses for two weeks). At the time of the report, OROPHARYNGEAL DISCOMFORT (Throat pulses for two weeks) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Movement disorder, Pain in extremity, Peripheral swelling
Clinical narrative: swelling arm; pain in arm but much worse; I couldn't move my arm at all; It was very painful; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 02-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swelling arm), PAIN IN EXTREMITY (pain in arm but much worse), MOVEMENT DISORDER (I couldn't move my arm at all) and PAIN IN EXTREMITY (It was very painful) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Surgery (Right arm) in November 2020.   On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (swelling arm), PAIN IN EXTREMITY (pain in arm but much worse), MOVEMENT DISORDER (I couldn't move my arm at all) and PAIN IN EXTREMITY (It was very painful). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Swelling arm, at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (swelling arm), PAIN IN EXTREMITY (pain in arm but much worse), MOVEMENT DISORDER (I couldn't move my arm at all) and PAIN IN EXTREMITY (It was very painful) had not resolved.            Concomitant medications not reported. Reportedly, the patient had the first shot of vaccine about  a month ago from the second shot and experienced pain probably about an hour after, which lasted a day. Same reaction for second dose, but much worse which lasted 3 days.   This case was linked to MOD-2021-032012 (E2B Linked Report).; Sender's Comments:  MOD-2021-032012:cross linked case to wife: MOD21-042859 same reporter
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: high Fever 101.6; Nauseas; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (high Fever 101.6) and NAUSEA (Nauseas) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (high Fever 101.6) and NAUSEA (Nauseas). At the time of the report, PYREXIA (high Fever 101.6) and NAUSEA (Nauseas) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was reported.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Exposure during pregnancy, Pregnancy test, Ultrasound scan
Clinical narrative: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 33-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     Concurrent medical conditions included Constipation, Iron deficiency and Headache. Concomitant products included DOCUSATE SODIUM (COLACE) from 2021 to an unknown date for Constipation, PARACETAMOL (TYLENOL) from 2020 to an unknown date for Headache, IRON from 2021 to an unknown date for Iron deficiency, MINERALS NOS, VITAMINS NOS (ONE A DAY [MINERALS NOS;VITAMINS NOS]) from 2020 to an unknown date for Pregnancy.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 20-Jul-2020 and the estimated date of delivery was 10-May-2021. On 02-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-second week of the pregnancy.  On 02-Mar-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Sep-2020, Pregnancy test: positive (Positive) Positive. On an unknown date, Blood glucose: (normal) before vaccine. On an unknown date, Ultrasound scan: normal (normal) before vaccine.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Lab investigations included Anatomy scan and results were normal before vaccine. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: she has a sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (she has a sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. O14M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced PAIN IN EXTREMITY (she has a sore arm). At the time of the report, PAIN IN EXTREMITY (she has a sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was reported.
Sex: M
Vaccine: COVID19
Symptoms: Illness, Influenza like illness, Vaccination site erythema, Vaccination site inflammation, Vaccination site swelling
Clinical narrative: vaccination site inflammation; vaccination site swelling; vaccination site red mark; Illness; Flu like symtpoms; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Illness), INFLUENZA LIKE ILLNESS (Flu like symtpoms), VACCINATION SITE INFLAMMATION (vaccination site inflammation), VACCINATION SITE SWELLING (vaccination site swelling) and VACCINATION SITE ERYTHEMA (vaccination site red mark) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced ILLNESS (Illness) and INFLUENZA LIKE ILLNESS (Flu like symtpoms). On an unknown date, the patient experienced VACCINATION SITE INFLAMMATION (vaccination site inflammation), VACCINATION SITE SWELLING (vaccination site swelling) and VACCINATION SITE ERYTHEMA (vaccination site red mark). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, ILLNESS (Illness), INFLUENZA LIKE ILLNESS (Flu like symtpoms), VACCINATION SITE INFLAMMATION (vaccination site inflammation), VACCINATION SITE SWELLING (vaccination site swelling) and VACCINATION SITE ERYTHEMA (vaccination site red mark) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.    This case was linked to MOD-2021-032397 (Patient Link).
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Induration, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Hardness; Itchiness; Swelling at injection site; Redness; pain became worse; Pain in arm at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INDURATION (Hardness), CONDITION AGGRAVATED (pain became worse), VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE PAIN (Pain in arm at injection site) and VACCINATION SITE SWELLING (Swelling at injection site) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021A2114) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION SITE PAIN (Pain in arm at injection site). On 02-Mar-2021, the patient experienced CONDITION AGGRAVATED (pain became worse). On 03-Mar-2021, the patient experienced INDURATION (Hardness), VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE SWELLING (Swelling at injection site) and VACCINATION SITE ERYTHEMA (Redness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, INDURATION (Hardness), CONDITION AGGRAVATED (pain became worse), VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE PAIN (Pain in arm at injection site), VACCINATION SITE SWELLING (Swelling at injection site) and VACCINATION SITE ERYTHEMA (Redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.     Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Contact information was Updated.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Hardness; Itchiness; Swelling at injection site; Redness; pain became worse; Pain in arm at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INDURATION (Hardness), CONDITION AGGRAVATED (pain became worse), VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE PAIN (Pain in arm at injection site) and VACCINATION SITE SWELLING (Swelling at injection site) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021A2114) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION SITE PAIN (Pain in arm at injection site). On 02-Mar-2021, the patient experienced CONDITION AGGRAVATED (pain became worse). On 03-Mar-2021, the patient experienced INDURATION (Hardness), VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE SWELLING (Swelling at injection site) and VACCINATION SITE ERYTHEMA (Redness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, INDURATION (Hardness), CONDITION AGGRAVATED (pain became worse), VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE PAIN (Pain in arm at injection site), VACCINATION SITE SWELLING (Swelling at injection site) and VACCINATION SITE ERYTHEMA (Redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.     Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Contact information was Updated.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Chills; fever of 102°F; This spontaneous case was reported by a non-health professional and describes the occurrence of CHILLS (Chills) and PYREXIA (fever of 102°F) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced CHILLS (Chills) and PYREXIA (fever of 102°F). At the time of the report, CHILLS (Chills) and PYREXIA (fever of 102°F) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medication reported  No treatment information was provided
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Diarrhoea, Nausea, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Covid-19; diarrhea; nausea/vomiting; nausea/vomiting; fever; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19), DIARRHOEA (diarrhea), NAUSEA (nausea/vomiting), VOMITING (nausea/vomiting) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Covid-19), DIARRHOEA (diarrhea), NAUSEA (nausea/vomiting), VOMITING (nausea/vomiting) and PYREXIA (fever). At the time of the report, COVID-19 (Covid-19), DIARRHOEA (diarrhea), NAUSEA (nausea/vomiting), VOMITING (nausea/vomiting) and PYREXIA (fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test positive: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported  No treatment information was provided
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Covid-19; diarrhea; nausea/vomiting; nausea/vomiting; fever; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19), DIARRHOEA (diarrhea), NAUSEA (nausea/vomiting), VOMITING (nausea/vomiting) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Covid-19), DIARRHOEA (diarrhea), NAUSEA (nausea/vomiting), VOMITING (nausea/vomiting) and PYREXIA (fever). At the time of the report, COVID-19 (Covid-19), DIARRHOEA (diarrhea), NAUSEA (nausea/vomiting), VOMITING (nausea/vomiting) and PYREXIA (fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test positive: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported  No treatment information was provided
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Feeling abnormal, Pain in extremity, Pollakiuria
Clinical narrative: Little bit pain in the arm; Feel dizzied; felt awful; frequent urination; Had 101.1 and felt awful; Violent chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Little bit pain in the arm), DIZZINESS (Feel dizzied), FEELING ABNORMAL (felt awful), POLLAKIURIA (frequent urination) and PYREXIA (Had 101.1 and felt awful) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included High cholesterol and Blood pressure high. Concomitant products included multivitamin (MULTIVITAMINS, PLAIN), LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Little bit pain in the arm), DIZZINESS (Feel dizzied), FEELING ABNORMAL (felt awful), POLLAKIURIA (frequent urination), PYREXIA (Had 101.1 and felt awful) and CHILLS (Violent chills). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE, PARACETAMOL (TYLENOL PM EXTRA STRENGTH) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Little bit pain in the arm), DIZZINESS (Feel dizzied), FEELING ABNORMAL (felt awful), POLLAKIURIA (frequent urination), PYREXIA (Had 101.1 and felt awful) and CHILLS (Violent chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Little bit pain in the arm; Feel dizzied; felt awful; frequent urination; Had 101.1 and felt awful; Violent chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Little bit pain in the arm), DIZZINESS (Feel dizzied), FEELING ABNORMAL (felt awful), POLLAKIURIA (frequent urination) and PYREXIA (Had 101.1 and felt awful) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included High cholesterol and Blood pressure high. Concomitant products included multivitamin (MULTIVITAMINS, PLAIN), LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Little bit pain in the arm), DIZZINESS (Feel dizzied), FEELING ABNORMAL (felt awful), POLLAKIURIA (frequent urination), PYREXIA (Had 101.1 and felt awful) and CHILLS (Violent chills). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE, PARACETAMOL (TYLENOL PM EXTRA STRENGTH) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Little bit pain in the arm), DIZZINESS (Feel dizzied), FEELING ABNORMAL (felt awful), POLLAKIURIA (frequent urination), PYREXIA (Had 101.1 and felt awful) and CHILLS (Violent chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Erythema
Clinical narrative: arm became bright red; black like a bruise; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (arm became bright red) and CONTUSION (black like a bruise) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced ERYTHEMA (arm became bright red) and CONTUSION (black like a bruise). At the time of the report, ERYTHEMA (arm became bright red) and CONTUSION (black like a bruise) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported  No treatment information was provided
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site rash, Vaccination site swelling
Clinical narrative: Vaccination site rash; Vaccination site swelling; Vaccination site pain; Vaccination site erythema; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE RASH (Vaccination site rash), VACCINATION SITE SWELLING (Vaccination site swelling), VACCINATION SITE PAIN (Vaccination site pain) and VACCINATION SITE ERYTHEMA (Vaccination site erythema) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 023M20A) for COVID-19 vaccination.     Concomitant products included NAPROXEN SODIUM (ALEVE), MIRABEGRON, AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) and VITAMIN D [VITAMIN D NOS] for an unknown indication.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Jan-2021, the patient experienced VACCINATION SITE RASH (Vaccination site rash), VACCINATION SITE SWELLING (Vaccination site swelling), VACCINATION SITE PAIN (Vaccination site pain) and VACCINATION SITE ERYTHEMA (Vaccination site erythema). The patient was treated with HYDRALAZINE HYDROCHLORIDE (APREZIN) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, VACCINATION SITE RASH (Vaccination site rash), VACCINATION SITE SWELLING (Vaccination site swelling), VACCINATION SITE PAIN (Vaccination site pain) and VACCINATION SITE ERYTHEMA (Vaccination site erythema) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-031995 (Patient Link).
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash all over body; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash all over body) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     Concomitant products included POTASSIUM, BUMETANIDE, PRAVASTATIN, AMIODARONE and WARFARIN for an unknown indication.   On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced RASH (rash all over body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash, at an unspecified dose and frequency. At the time of the report, RASH (rash all over body) had not resolved.            Action taken with mRNA-1273 in response to the event was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: Received the vaccine while pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Received the vaccine while pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 19-Sep-2020 and the estimated date of delivery was 26-Jun-2021. On 18-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Received the vaccine while pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-first week of the pregnancy.  On 18-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Received the vaccine while pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was reported.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: Body aches; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Body aches) and HEADACHE (Headache). At the time of the report, MYALGIA (Body aches) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 31-year-old female patient (gravida 3, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (during first trimester Incarcerated Uterus - It was fixed) and Alcohol use (Once a week) in 2020. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Pregnancy.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 14-Nov-2020 and the estimated date of delivery was 19-Aug-2021. On 26-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fourteenth week of the pregnancy.  On 26-Feb-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.            No treatment information was reported.  On Unknown dates, Ultrasound and chromosomal Abnormalities test were performed on patient with normal results  The patient's date of positive pregnancy test was 06-DEC-2020.  The patient previously had live birth with no complications on 27-MAR-2018 The patient previously had a miscarriage on JUL-2020
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Rash on injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash on injection site) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No prior medical history was reported.     On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced VACCINATION SITE RASH (Rash on injection site). At the time of the report, VACCINATION SITE RASH (Rash on injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported included antihistamines for product use of unknown indication.  Reported treatment medication including antihistamine. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Feb-2021 and was forwarded to Moderna on 12-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash on injection site) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No prior medical history was reported.     On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced VACCINATION SITE RASH (Rash on injection site). At the time of the report, VACCINATION SITE RASH (Rash on injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported included antihistamines for product use of unknown indication.  Reported treatment medication including antihistamine.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever of 100°C; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 100°C) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced PYREXIA (Fever of 100°C). At the time of the report, PYREXIA (Fever of 100°C) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Haematuria, Myalgia, Nausea, Pyrexia
Clinical narrative: Blood in urine; chills; Fever; Nauseous; Aching; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (Fever), NAUSEA (Nauseous), MYALGIA (Aching) and HAEMATURIA (Blood in urine) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 027L20A) for COVID-19 vaccination.     Concurrent medical conditions included Kidney stones (Patient has kidney stones in his left kidney.).   On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to at an unspecified dose. On 01-Mar-2021, the patient experienced CHILLS (chills), PYREXIA (Fever), NAUSEA (Nauseous) and MYALGIA (Aching). On 02-Mar-2021, the patient experienced HAEMATURIA (Blood in urine). On 01-Mar-2021, CHILLS (chills), PYREXIA (Fever) and MYALGIA (Aching) had resolved. At the time of the report, NAUSEA (Nauseous) and HAEMATURIA (Blood in urine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Relevant concomitant medication was reported blood pressure and cholesterol medicine. No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 03-Mar-2021: No specific follow-up information recorded.